NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.33%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$21.8M
(+2.2%)
Cap. Flow
-$93.3M
Cap. Flow
% of AUM
-9.14%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
137
New
19
Increased
22
Reduced
37
Closed
18
Top Buys
| 1 |
Peloton Interactive
PTON
|
+$13.1M |
| 2 |
Tourmaline Bio
TRML
|
+$6.64M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$6.6M |
| 4 |
eHealth
EHTH
|
+$5.55M |
| 5 |
CONN
Conn's Inc.
CONN
|
+$4.73M |
Top Sells
| 1 |
Establishment Labs
ESTA
|
+$25.7M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$19.7M |
| 3 |
Soleno Therapeutics
SLNO
|
+$19.1M |
| 4 |
Luxfer Holdings
LXFR
|
+$11.7M |
| 5 |
Cytokinetics
CYTK
|
+$9.19M |
Sector Composition
| 1 | Healthcare | 63.23% |
| 2 | Consumer Discretionary | 13.84% |
| 3 | Financials | 7.05% |
| 4 | Communication Services | 5.88% |
| 5 | Technology | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elutia
ELUT
$79.7M
| $5.2M | 0.3% |
1,650,000
| – | – |
|
|
AGS
52
DELISTED
PlayAGS
AGS
| $5.09M | 0.29% |
566,588
| – | – |
|
53
DHI Group
DHX
$143M
| $5.01M | 0.29% |
1,966,417
-673,270
| -26% | -$1.72M |
|
54
InspireMD
NSPR
$100M
| $4.9M | 0.28% |
2,066,456
| – | – |
|
55
Xtant Medical Holdings
XTNT
$79.9M
| $4.68M | 0.27% |
4,000,000
| – | – |
|
56
Enova International
ENVA
$2.96B
| $4.52M | 0.26% |
71,865
| – | – |
|
|
THTX
57
Theratechnologies
THTX
$150M
| $4.45M | 0.25% |
2,682,228
| – | – |
|
|
SLN
58
Silence Therapeutics
SLN
$254M
| $4.32M | 0.25% |
+200,000
| New | +$4.32M |
|
59
Mineralys Therapeutics
MLYS
$2.79B
| $4.29M | 0.25% |
+332,506
| New | +$4.29M |
|
60
Vanda Pharmaceuticals
VNDA
$269M
| $4.16M | 0.24% |
1,013,251
| – | – |
|
61
NewAmsterdam Pharma
NAMS
$2.83B
| $4.14M | 0.24% |
+175,000
| New | +$4.14M |
|
62
DarioHealth
DRIO
$22.1M
| $4.03M | 0.23% |
131,628
+14,790
| +13% | +$453K |
|
63
SPDR S&P Biotech ETF
XBI
$5.33B
| $3.99M | 0.23% |
+42,069
| New | +$3.99M |
|
64
Neurogene
NGNE
$278M
| $3.68M | 0.21% |
72,279
| – | – |
|
|
OPTN
65
DELISTED
OptiNose
OPTN
| $3.61M | 0.21% |
164,953
-44,842
| -21% | -$982K |
|
66
AYTU BioPharma
AYTU
$20.4M
| $3.3M | 0.19% |
1,086,812
| – | – |
|
67
Milestone Pharmaceuticals
MIST
$149M
| $3.13M | 0.18% |
+1,750,000
| New | +$3.13M |
|
68
The ONE Group
STKS
$84.2M
| $3.05M | 0.17% |
+547,710
| New | +$3.05M |
|
69
MediaAlpha
MAX
$713M
| $3.04M | 0.17% |
149,371
-31,497
| -17% | -$642K |
|
70
Achieve Life Sciences
ACHV
$150M
| $2.97M | 0.17% |
+654,000
| New | +$2.97M |
|
71
Gaia
GAIA
$140M
| $2.82M | 0.16% |
915,029
| – | – |
|
72
enVVeno Medical
NVNO
$14.6M
| $2.7M | 0.15% |
495,736
-210,583
| -30% | -$1.15M |
|
|
JBIO
73
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $2.7M | 0.15% |
2,605
| – | – |
|
74
Nektar Therapeutics
NKTR
$843M
| $2.31M | 0.13% |
+165,064
| New | +$2.31M |
|
75
Altisource Portfolio Solutions
ASPS
$126M
| $2.12M | 0.12% |
136,376
+3,362
| +3% | +$52.2K |
|